OSMCX | WIIGX | OSMCX / WIIGX | |
Total Expense Ratio | 2.13 | 1.36 | 157% |
Annual Report Gross Expense Ratio | 2.13 | 1.38 | 154% |
Fund Existence | 28 years | 10 years | - |
Gain YTD | 18.606 | 18.852 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.66B | 218M | 1,680% |
Annual Yield % from dividends | 0.47 | 0.00 | - |
Returns for 1 year | -4.05 | -5.88 | 69% |
Returns for 3 years | 17.28 | 12.05 | 143% |
Returns for 5 years | -22.31 | -27.84 | 80% |
Returns for 10 years | 9.86 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTDX | 123.90 | N/A | N/A |
Franklin Biotechnology Discovery C | |||
VLPIX | 16.46 | N/A | N/A |
Virtus Duff & Phelps Sel MLP & Engy I | |||
OFVIX | 21.41 | N/A | N/A |
O'Shaughnessy Market Leaders Value I | |||
BRMAX | 16.05 | -0.01 | -0.06% |
iShares Russell Mid-Cap Index Inv A | |||
DFIVX | 26.95 | -0.19 | -0.70% |
DFA International Value I |